Maria Elena Capra

ORCID: 0000-0003-0848-5228
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lipoproteins and Cardiovascular Health
  • Obesity, Physical Activity, Diet
  • Diet and metabolism studies
  • Birth, Development, and Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cancer, Lipids, and Metabolism
  • Infant Nutrition and Health
  • Child Nutrition and Feeding Issues
  • Diet, Metabolism, and Disease
  • Breastfeeding Practices and Influences
  • Nutrition, Genetics, and Disease
  • Forensic and Genetic Research
  • Forensic Anthropology and Bioarchaeology Studies
  • Cholesterol and Lipid Metabolism
  • Fatty Acid Research and Health
  • Allergic Rhinitis and Sensitization
  • Lipid metabolism and disorders
  • Food Allergy and Anaphylaxis Research
  • Radioactivity and Radon Measurements
  • Body Contouring and Surgery
  • Atherosclerosis and Cardiovascular Diseases
  • Infant Health and Development
  • Consumer Attitudes and Food Labeling
  • Child and Adolescent Health
  • Agriculture Sustainability and Environmental Impact

Guglielmo da Saliceto Hospital
2017-2025

University of Parma
2022-2024

Italian Society of Physiotherapy
2024

Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione
2023

Ospedale Policlinico San Martino
2017

University of Milan
2003-2013

According to WHO, “complementary feeding (CF) is the process starting when breast milk alone or infant formula no longer sufficient meet nutritional requirements of infants, and therefore, other foods liquids are needed, along with human a breastmilk substitute”. CF one most important “critical sensitive periods” in life: indeed, timing approaches solid introduction an infant’s nutrition utmost importance as potential epigenetic factors from infancy adulthood. also deeply influenced by each...

10.3390/nu16050737 article EN Nutrients 2024-03-04
Angela Pirillo K. Garlaschelli Marcello Arca Maurizio Averna S Bertolini and 95 more S. Calandra Patrizia Tarugi Alberico L. Catapano Marcello Arca Maurizio Averna S Bertolini S. Calandra Alberico L. Catapano Patrizia Tarugi Fabio Pellegatta Francesco Angelico Marcello Arca Maurizio Averna Andrea Bartuli Giacomo Biasucci Gianni Biolo Luca Bonanni Katia Bonomo Claudio Borghi Antonio Bossi Adriana Branchi Francesca Carubbi Francesco Cipollone Nadia Citroni Massimo Federici Claudio Ferri A.M. Fiorenza Andrea Giaccari Francesco Giorgino Ornella Guardamagna Marcello Arca Lorenzo Iughetti Graziana Lupattelli Giuseppe Mandraffino Rossella Marcucci Giuliana Mombelli Sandro Muntoni Valerio Pecchioli Cristina Pederiva A. E. Pípolo Livia Pisciotta Arturo Pujia Francesco Purrello Elena Repetti Paolo Rubba Carlo Sabbà Tiziana Sampietro Riccardo Sarzani Milena Tagliabue Chiara Trenti Giovanni Battista Vigna José Pablo Werba Sabina Zambon Maria Grazia Zenti Anna Montali Davide Noto S Bertolini S. Calandra Giuliana Fortunato Liliana Grigore Maria Del Ben Marianna Maranghi Angelo Baldassarre Cefalù Paola Sabrina Buonuomo Maria Elena Capra Pierandrea Vinci Sergio D’Addato Stella Galbiati Fabio Nascimbeni Marco Bucci Walter Spagnoli Iris Cardolini Nazzareno Cervelli Emanuela Colombo Vinsin A. Sun Luigi Laviola Francesca Bello Giuseppe Chiariello Barbara Predieri Donatella Siepi Antonino Saitta Betti Giusti Chiara Pavanello Milena Lussu Lucia Prati Giuseppe Banderali Giulia Balleari Tiziana Montalcini Roberto Scicali Luigi Gentile Marco Gentile Patrizia Suppressa Francesco Sbrana Guido Cocci Andrea Benso

Familial hypercholesterolemia (FH) is an autosomal dominant disease characterized by elevated plasma levels of LDL-cholesterol that confers increased risk premature atherosclerotic cardiovascular disease. Early identification and treatment FH patients can improve prognosis reduce the burden mortality. Aim this study was to perform mutational analysis identified through a collaboration 20 Lipid Clinics in Italy (LIPIGEN Study). We recruited 1592 individuals with clinical diagnosis definite or...

10.1016/j.atherosclerosissup.2017.07.002 article EN cc-by-nc-nd Atherosclerosis Supplements 2017-09-28
Maurizio Averna Angelo B. Cefalù Manuela Casula Davide Noto Marcello Arca and 95 more Stefano Bertolini S. Calandra Alberico L. Catapano Patrizia Tarugi Marcello Arca Maurizio Averna Stefano Bertolini S. Calandra Alberico L. Catapano Patrizia Tarugi Fabio Pellegatta Francesco Angelico Marcello Arca Maurizio Averna Andrea Bartuli Giacomo Biasucci Gianni Biolo Luca Bonanni Katia Bonomo Claudio Borghi Antonio Bossi Adriana Branchi Francesca Carubbi Francesco Cipollone Nadia Citroni Massimo Federici Claudio Ferri A.M. Fiorenza Andrea Giaccari Francesco Giorgino Ornella Guardamagna Marcello Arca Lorenzo Iughetti Graziana Lupattelli Giuseppe Mandraffino Rossella Marcucci Giuliana Mombelli Sandro Muntoni Valerio Pecchioli Cristina Pederiva A. E. Pípolo Livia Pisciotta Arturo Pujia Francesco Purrello Elena Repetti Paolo Rubba Carlo Sabbà Tiziana Sampietro Riccardo Sarzani Milena Tagliabue Chiara Trenti Giovanni Battista Vigna José Pablo Werba Sabina Zambon Maria Grazia Zenti Anna Montali Davide Noto Stefano Bertolini S. Calandra Giuliana Fortunato Liliana Grigore Maria Del Ben Marianna Maranghi Angelo B. Cefalù Carlo M. Barbagallo Paola Sabrina Buonuomo Maria Elena Capra Pierandrea Vinci Sergio D’Addato Stella Galbiati Fabio Nascimbeni Marco Bucci Walter Spagnoli Iris Cardolini Nazzareno Cervelli Emanuela Colombo A. Sun Vinsin Luigi Laviola Francesca Bello Giuseppe Chiariello Barbara Predieri Donatella Siepi Antonino Saitta Betti Giusti Chiara Pavanello Milena Lussu Lucia Prati Giuseppe Banderali Giulia Balleari Tiziana Montalcini Roberto Scicali Luigi Gentile Marco Gentile Patrizia Suppressa Francesco Sbrana

Primary dyslipidemias are a heterogeneous group of disorders characterized by abnormal levels circulating lipoproteins. Among them, familial hypercholesterolemia is the most common lipid disorder that predisposes for premature cardiovascular disease. We set up an Italian nationwide network aimed at facilitating clinical and genetic diagnosis named LIPIGEN (LIpid TransPort Disorders GEnetic Network). Observational, multicenter, retrospective prospective study involving about 40 centers....

10.1016/j.atherosclerosissup.2017.07.001 article EN cc-by-nc-nd Atherosclerosis Supplements 2017-09-28

The prevalence and characteristics of polyneuropathy were assessed using standard clinical electrophysiological criteria in 39 consecutive outpatients with primary hypothyroidism, 15 whom previously untreated. Subjective complaints, mainly paraesthesiae, recorded from 25 cases (64%) objective findings supporting a diagnosis present 13 (33%). Using criteria, definite was made 28 (72%). commonest sites abnormal nerve conduction the sensory nerves, especially sural nerve. Polyneuropathy...

10.1136/jnnp.52.12.1420 article EN Journal of Neurology Neurosurgery & Psychiatry 1989-12-01

The atherosclerotic process begins in childhood and progresses throughout adult age. Hypercholesterolemia, especially familial hypercholesterolemia (FH) metabolic dysfunctions linked to weight excess obesity, are the main atherosclerosis risk factors pediatric patients can be detected treated starting from childhood. Nutritional intervention a healthy-heart lifestyle cornerstones first-line treatments, with which, if necessary, drug therapy should associated. For several years, functional...

10.3390/children11010129 article EN cc-by Children 2024-01-20

Familial hypercholesterolemia is a genetically determined disease characterized by elevated plasma total and LDL cholesterol levels from the very first years of life, leading to early atherosclerosis. Nutritional intervention first-line treatment, complemented with nutraceuticals drug therapy when necessary. Nutraceuticals lipid-lowering effect have been extensively studied in past few decades, recently included international guidelines as complement nutritional pharmacological treatment...

10.3390/children11020250 article EN cc-by Children 2024-02-15

Background: Awareness, diagnosis, and treatment of familial hypercholesterolemia (FH) starting from childhood are a cornerstone cardiovascular disease prevention. The LIPIGEN Paediatric Group, network specialised centres for the diagnosis management genetic dyslipidemia, is an active part this mission. Materials Methods: This second exploratory survey organised within (LIpid transPort disorders Italian GEnetic Network) paediatric centres. A digital questionnaire consisting 16 questions was...

10.3390/children12030288 article EN cc-by Children 2025-02-26

Dietary fiber is present in many food categories (fruits, cereals, vegetables, legumes), and considered a beneficial component of adult children’s diets. It now well-established that dietary intervention the first line treatment for childhood dyslipidemia, both as curative (Familial Hyperchylomicronemia Syndrome, Sitosterolemia) an appropriate lifestyle aimed at improving lipid profile which associated with early atherosclerosis increased risk cardiovascular disease adulthood...

10.3390/children12040427 article EN cc-by Children 2025-03-28

Headache is the most frequent neurological symptom in childhood and main reason for admission to pediatric emergency departments. The aim of this consensus document define a shared clinical pathway between primary care pediatricians (PCP) hospitals management children presenting with headache. For purposes study, group hospital PCP from Emilia Romagna's health districts were selected achieve using RAND/UCLA appropriateness method. Thirty-nine scenarios developed: each scenario, participants...

10.3390/life12020142 article EN cc-by Life 2022-01-19
Coming Soon ...